Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:1594-1596
Published online before print June 2, 2005, doi: 10.1161/01.STR.0000170701.41507.e1
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/7/1594    most recent
01.STR.0000170701.41507.e1v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keep, R. F.
Right arrow Articles by Hoff, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keep, R. F.
Right arrow Articles by Hoff, J. T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*IRON
Related Collections
Right arrow Other Stroke Treatment - Medical
Right arrow Coagulation
Right arrow Thrombin
Right arrow Animal models of human disease
Right arrow Acute Cerebral Hemorrhage

(Stroke. 2005;36:1594.)
© 2005 American Heart Association, Inc.


Comments, Opinions, and Reviews

The Deleterious or Beneficial Effects of Different Agents in Intracerebral Hemorrhage

Think Big, Think Small, or Is Hematoma Size Important?

Richard F. Keep, PhD; Guohua Xi, MD; Ya Hua, MD Julian T. Hoff, MD

From the Departments of Neurosurgery (R.F.K., G.X. Y.H., J.T.H.) and Physiology (R.F.K.), University of Michigan, Ann Arbor, Mich.

Correspondence to Richard F. Keep, PhD, Department of Neurosurgery, University of Michigan, 5550 Kresge I, Ann Arbor, MI 48109-0532. E-mail rkeep{at}umich.edu

Background and Purpose— Thrombin, heme oxygenase, complement, microglia activation, and leukocyte infiltration are all actively upregulated in intracerebral hemorrhage (ICH). Experimental evidence suggests that all these factors are involved in ICH-induced brain injury. This suggests a scenario whereby ICH actively (through gene and protein upregulation) induces pathways that result in brain injury.

Summary of Review— In this comment, we suggest a potential answer to this conundrum. The upregulation of these factors may have been an evolutionary adaptation to limit brain injury during small hematomas (microbleeds). There is evidence that low levels of thrombin and heme oxygenase limit brain injury. In contrast, the excessive upregulation of these same factors may have a harmful effect after a large hematoma.

Conclusion— The mechanisms upregulated to limit brain injury after microbleeds may also induce injury after large hematomas. The effect of hematoma size on the mechanisms involved in ICH-induced brain injury and the implications of any such effect on clinical therapies merit further investigation.


Key Words: inflammation • iron • thrombin




This article has been cited by other articles:


Home page
BrainHome page
J. Wang and S. Dore
Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage
Brain, June 1, 2007; 130(6): 1643 - 1652.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. R. Wagner
Modeling Intracerebal Hemorrhage: Glutamate, Nuclear Factor-{kappa}B Signaling and Cytokines
Stroke, February 1, 2007; 38(2): 753 - 758.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. A. Swanson
Intracerebral Hematoma: Beyond the Mass Lesion
Stroke, October 1, 2006; 37(10): 2445 - 2445.
[Full Text] [PDF]